New president for Valeant Pharmaceuticals International
This article was originally published in Scrip
Valeant Pharmaceuticals has appointed Dr Bhaskar Chaudhuri to the position of president of Valeant Pharmaceuticals International. He will assume responsibility for overseeing the Dow Services business, corporate business development activities, the branded generics operations in Mexico and Poland, and will be a member of Valeant's executive management team. Dr Chaudhuri was previously president and CEO of Dow Pharmaceutical Sciences and was on its board before its acquisition by Valeant.